0001104659-21-075899.txt : 20210602
0001104659-21-075899.hdr.sgml : 20210602
20210602191354
ACCESSION NUMBER: 0001104659-21-075899
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210602
FILED AS OF DATE: 20210602
DATE AS OF CHANGE: 20210602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAPOINTE ANTHONY GREGG
CENTRAL INDEX KEY: 0001331860
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 21990789
MAIL ADDRESS:
STREET 1: PO BOX 83216
CITY: GAITHERSBURG
STATE: MD
ZIP: 20883-3216
FORMER NAME:
FORMER CONFORMED NAME: Lapointe Gregg Anthony
DATE OF NAME CHANGE: 20050630
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 HIGH STREET
STREET 2: 28TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: 100 HIGH STREET
STREET 2: 28TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
tm2118270-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-06-02
0
0001454789
CATABASIS PHARMACEUTICALS INC
CATB
0001331860
LAPOINTE ANTHONY GREGG
C/O CATABASIS PHARMACEUTICALS, INC.,
100 HIGH STREET, FLOOR 28
BOSTON
MA
02110
1
0
0
0
Stock Option (right to buy)
2.04
2021-06-02
4
A
0
100000
0
A
2031-06-01
Common Stock
100000
100000
D
This option was granted on June 2, 2021 and is schedule to vest in equal annual installments over a three-year period from the date of grant, subject to the director's continued service.
/s/ Ben Harshbarger, as attorney-in-fact for Gregg Anthony LaPointe
2021-06-02